痛風治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Gout Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8102805)・商品コード:GIR8102805
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月9日
・ページ数:135
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、痛風治療の世界市場について調べ、まとめました。種類別セグメントは、NSAIDs、コルチコステロイド、コルヒチン、尿酸低下剤等、用途別セグメントは、急性痛風、慢性痛風等に区分しました。痛風治療の世界市場概観、メーカー動向、メーカー別痛風治療シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・痛風治療の市場概観
・痛風治療のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・痛風治療のメーカー別販売動向、市場シェア、市場集中度、競争動向
・痛風治療の世界市場規模
・痛風治療の北米市場分析(アメリカ、カナダ、メキシコ等)
・痛風治療のアメリカ市場規模推移
・痛風治療のカナダ市場規模推移
・痛風治療のメキシコ市場規模推移
・痛風治療のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・痛風治療のドイツ市場規模推移
・痛風治療のイギリス市場規模推移
・痛風治療のロシア市場規模推移
・痛風治療のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・痛風治療の日本市場規模推移
・痛風治療の中国市場規模推移
・痛風治療の韓国市場規模推移
・痛風治療のインド市場規模推移
・痛風治療の東南アジア市場規模推移
・痛風治療の南米市場分析(ブラジル、アルゼンチン等)
・痛風治療の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・痛風治療の種類別分析/市場規模推移(NSAIDs、コルチコステロイド、コルヒチン、尿酸低下剤)
・痛風治療の用途別分析/市場規模推移(急性痛風、慢性痛風)
・痛風治療の市場予測(地域別予測、種類別予測、用途別予測)
・痛風治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries.

Scope of the Report:

This report studies the Gout Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gout Therapeutics market by product type and applications/end industries.

Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.

At present, the Americas is the largest market for gout therapeutics and is estimated to retain its hold over the market until the end of 2020. The market in this region is growing briskly due to the higher incidences of gout in the US, which results in the growing consumption of gout drugs. In this region, novel therapies like llaris and lesinurad FDC are expected to launch during the forecast period in the US as they have proven benefits over the standard of care. This indicates that novel therapies will have a favorable market potential and good market success during the forecast period.

The global Gout Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gout Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Takeda Pharmaceutical Company

Novartis

AstraZeneca

GlaxoSmithKline

Merck

Regeneron Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

NSAIDs

Corticosteroids

Colchicine

Urate-Lowering Agents

Market Segment by Applications, can be divided into

Acute Gout

Chronic Gout

【レポートの目次】

Table of Contents

1 Gout Therapeutics Market Overview

1.1 Product Overview and Scope of Gout Therapeutics

1.2 Classification of Gout Therapeutics by Types

1.2.1 Global Gout Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Gout Therapeutics Revenue Market Share by Types in 2017

1.2.3 NSAIDs

1.2.4 Corticosteroids

1.2.5 Colchicine

1.2.6 Urate-Lowering Agents

1.3 Global Gout Therapeutics Market by Application

1.3.1 Global Gout Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Acute Gout

1.3.3 Chronic Gout

1.4 Global Gout Therapeutics Market by Regions

1.4.1 Global Gout Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Gout Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Gout Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gout Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Gout Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gout Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Gout Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Takeda Pharmaceutical Company

2.1.1 Business Overview

2.1.2 Gout Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Takeda Pharmaceutical Company Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novartis

2.2.1 Business Overview

2.2.2 Gout Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 AstraZeneca

2.3.1 Business Overview

2.3.2 Gout Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AstraZeneca Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 GlaxoSmithKline

2.4.1 Business Overview

2.4.2 Gout Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 GlaxoSmithKline Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Merck

2.5.1 Business Overview

2.5.2 Gout Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Merck Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Regeneron Pharmaceuticals

2.6.1 Business Overview

2.6.2 Gout Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Regeneron Pharmaceuticals Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Gout Therapeutics Market Competition, by Players

3.1 Global Gout Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Gout Therapeutics Players Market Share

3.2.2 Top 10 Gout Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Gout Therapeutics Market Size by Regions

4.1 Global Gout Therapeutics Revenue and Market Share by Regions

4.2 North America Gout Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Gout Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Gout Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Gout Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Gout Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Gout Therapeutics Revenue by Countries

5.1 North America Gout Therapeutics Revenue by Countries (2013-2018)

5.2 USA Gout Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Gout Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Gout Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Gout Therapeutics Revenue by Countries

6.1 Europe Gout Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Gout Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Gout Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Gout Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Gout Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Gout Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Gout Therapeutics Revenue by Countries

7.1 Asia-Pacific Gout Therapeutics Revenue by Countries (2013-2018)

7.2 China Gout Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Gout Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Gout Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Gout Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Gout Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Gout Therapeutics Revenue by Countries

8.1 South America Gout Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Gout Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Gout Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Gout Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Gout Therapeutics by Countries

9.1 Middle East and Africa Gout Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Gout Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Gout Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Gout Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Gout Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Gout Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Gout Therapeutics Market Segment by Type

10.1 Global Gout Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Gout Therapeutics Market Forecast by Type (2018-2023)

10.3 NSAIDs Revenue Growth Rate (2013-2023)

10.4 Corticosteroids Revenue Growth Rate (2013-2023)

10.5 Colchicine Revenue Growth Rate (2013-2023)

10.6 Urate-Lowering Agents Revenue Growth Rate (2013-2023)

11 Global Gout Therapeutics Market Segment by Application

11.1 Global Gout Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Gout Therapeutics Market Forecast by Application (2018-2023)

11.3 Acute Gout Revenue Growth (2013-2018)

11.4 Chronic Gout Revenue Growth (2013-2018)

12 Global Gout Therapeutics Market Size Forecast (2018-2023)

12.1 Global Gout Therapeutics Market Size Forecast (2018-2023)

12.2 Global Gout Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Gout Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Gout Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Gout Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Gout Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Gout Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Gout Therapeutics Picture

Table Product Specifications of Gout Therapeutics

Table Global Gout Therapeutics and Revenue (Million USD) Market Split by Product Type

Figure Global Gout Therapeutics Revenue Market Share by Types in 2017

Figure NSAIDs Picture

Figure Corticosteroids Picture

Figure Colchicine Picture

Figure Urate-Lowering Agents Picture

Table Global Gout Therapeutics Revenue (Million USD) by Application (2013-2023)

Figure Gout Therapeutics Revenue Market Share by Applications in 2017

Figure Acute Gout Picture

Figure Chronic Gout Picture

Table Global Market Gout Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Gout Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Gout Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Gout Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Gout Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Gout Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Gout Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Table Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors

Table Takeda Pharmaceutical Company Gout Therapeutics Type and Applications

Table Takeda Pharmaceutical Company Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Gout Therapeutics Type and Applications

Table Novartis Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Gout Therapeutics Type and Applications

Table AstraZeneca Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Gout Therapeutics Type and Applications

Table GlaxoSmithKline Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Gout Therapeutics Type and Applications

Table Merck Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Regeneron Pharmaceuticals Gout Therapeutics Type and Applications

Table Regeneron Pharmaceuticals Gout Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Global Gout Therapeutics Revenue (Million USD) by Players (2013-2018)

Table Global Gout Therapeutics Revenue Share by Players (2013-2018)

Figure Global Gout Therapeutics Revenue Share by Players in 2016

Figure Global Gout Therapeutics Revenue Share by Players in 2017

Figure Global Top 5 Players Gout Therapeutics Revenue Market Share in 2017

Figure Global Top 10 Players Gout Therapeutics Revenue Market Share in 2017

Figure Global Gout Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Gout Therapeutics Revenue (Million USD) by Regions (2013-2018)

Table Global Gout Therapeutics Revenue Market Share by Regions (2013-2018)

Figure Global Gout Therapeutics Revenue Market Share by Regions (2013-2018)

Figure Global Gout Therapeutics Revenue Market Share by Regions in 2017

Figure North America Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Europe Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure South America Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Gout Therapeutics Revenue and Growth Rate (2013-2018)

Table North America Gout Therapeutics Revenue by Countries (2013-2018)

Table North America Gout Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Gout Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Gout Therapeutics Revenue Market Share by Countries in 2017

Figure USA Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Canada Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Mexico Gout Therapeutics Revenue and Growth Rate (2013-2018)

Table Europe Gout Therapeutics Revenue (Million USD) by Countries (2013-2018)

Figure Europe Gout Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Europe Gout Therapeutics Revenue Market Share by Countries in 2017

Figure Germany Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure UK Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure France Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Russia Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Italy Gout Therapeutics Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Gout Therapeutics Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Gout Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Gout Therapeutics Revenue Market Share by Countries in 2017

Figure China Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Japan Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Korea Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure India Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Gout Therapeutics Revenue and Growth Rate (2013-2018)

Table South America Gout Therapeutics Revenue by Countries (2013-2018)

Table South America Gout Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Gout Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Gout Therapeutics Revenue Market Share by Countries in 2017

Figure Brazil Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Argentina Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Colombia Gout Therapeutics Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Gout Therapeutics Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Gout Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Gout Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Gout Therapeutics Revenue Market Share by Countries in 2017

Figure Saudi Arabia Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure UAE Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Egypt Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure Nigeria Gout Therapeutics Revenue and Growth Rate (2013-2018)

Figure South Africa Gout Therapeutics Revenue and Growth Rate (2013-2018)

Table Global Gout Therapeutics Revenue (Million USD) by Type (2013-2018)

Table Global Gout Therapeutics Revenue Share by Type (2013-2018)

Figure Global Gout Therapeutics Revenue Share by Type (2013-2018)

Figure Global Gout Therapeutics Revenue Share by Type in 2017

Table Global Gout Therapeutics Revenue Forecast by Type (2018-2023)

Figure Global Gout Therapeutics Market Share Forecast by Type (2018-2023)

Figure Global NSAIDs Revenue Growth Rate (2013-2018)

Figure Global Corticosteroids Revenue Growth Rate (2013-2018)

Figure Global Colchicine Revenue Growth Rate (2013-2018)

Figure Global Urate-Lowering Agents Revenue Growth Rate (2013-2018)

Table Global Gout Therapeutics Revenue by Application (2013-2018)

Table Global Gout Therapeutics Revenue Share by Application (2013-2018)

Figure Global Gout Therapeutics Revenue Share by Application (2013-2018)

Figure Global Gout Therapeutics Revenue Share by Application in 2017

Table Global Gout Therapeutics Revenue Forecast by Application (2018-2023)

Figure Global Gout Therapeutics Market Share Forecast by Application (2018-2023)

Figure Global Acute Gout Revenue Growth Rate (2013-2018)

Figure Global Chronic Gout Revenue Growth Rate (2013-2018)

Figure Global Gout Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Gout Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Gout Therapeutics Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Gout Therapeutics Revenue Market Forecast (2018-2023)

Figure Europe Gout Therapeutics Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Gout Therapeutics Revenue Market Forecast (2018-2023)

Figure South America Gout Therapeutics Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Gout Therapeutics Revenue Market Forecast (2018-2023)



【レポートのキーワード】

痛風治療、NSAIDs、コルチコステロイド、コルヒチン、尿酸低下剤、急性痛風、慢性痛風

★調査レポート[痛風治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8102805)販売に関する免責事項を必ずご確認ください。
★調査レポート[痛風治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆